Staying Abreast in Metastatic Breast Cancer
Staying Abreast in Metastatic Breast Cancer
Schedule: December 15, 2021, 2 to 3pm Live and Virtual
Dartmouth-Hitchcock Medical Center, Lebanon, NH
Audience: Accredited for Pharmacists
Other interested health care professionals welcome
Credits: 1 Contact Hour knowledge based
0.1CEU will be awarded under the provider
0837-9999-21-259-L01-P
Presenter: Alexandra Simms, PharmD, MS
PGY2 Oncology Pharmacy Resident, Dartmouth Hitchcock
Registration: Free to all attendees
Learning Objectives:
After attending this program, participants will be able to:
- Review the current treatment paradigm for management of metastatic breast cancer
- Analyze primary literature of newly approved agents for the treatment of metastatic breast cancer
- Discuss the various side effect profiles and counseling points for newly approved agents for the treatment of metastatic breast cancer
- Given a patient case, select the appropriate agent(s) for the treatment of metastatic breast cancer based on primary literature, patient specific factors, and medication safety profile
Requirements for Receiving CE Credit:
- Successful completion of post-presentation questions
- Participation at live program
- Complete program evaluation form